- Book
- February 2020
- 202 Pages
- Book
- December 2018
- 784 Pages
- Book
- July 2018
- 360 Pages
- Book
- April 2018
- 312 Pages
- Book
- May 2012
- 528 Pages
- Book
- January 2024
- 864 Pages
- Book
- December 2023
- 208 Pages
- Book
- December 2023
- 864 Pages
- Book
- August 2023
- 368 Pages
- Book
- April 2022
- 656 Pages
Global
T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more